Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
2023;15:e46623
Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors
Reliability and Quality
If more than 4 days have passed, skip the missed dose entirely and administer your next dose on the regularly scheduled day
Importantly, we found that addition of FXR-antagonistic BAs, including TMCA, HDCA or UDCA, could antagonize the effect of CDCA, a potent FXR agonist, on the mRNA expression of Shp and GLP-1 secretion in NCI-H716 cells (Fig
US$ 20.43
US$ 23.52
US$ 20.08
US$ 27.68
US$ 24.51
US$ 24.33
